Search Result "GLP1"
Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review
Journal: Current Vascular Pharmacology
Volume: 11 Issue: 6 Year: 2013 Page: 992-1000
Author(s): Evangelos C. Rizos,Evangelia E. Ntzani,Nikolaos Papanas,Vasilis Tsimihodimos,Zoi Mitrogianni,Efstratios Maltezos,Moses S. Elisaf
Glucagon-Like Peptide 1 and the Cardiovascular System
Journal: Current Diabetes Reviews
Volume: 10 Issue: 5 Year: 2014 Page: 302-310
Author(s): Stephen Fava
Evaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis
Journal: Current Radiopharmaceuticals
Volume: 10 Issue: 1 Year: 2017 Page: 65-72
Author(s): Bluma Linkowski Faintuch,Daniele Seo,Erica Aparecida de Oliveira,Roselaine Campos Targino,Ana Maria Moro
Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome Trials
Journal: Current Diabetes Reviews
Volume: 16 Issue: 9 Year: 2020 Page: 917-921
Author(s): Samit Ghosal,Binayak Sinha
Diabetes without Manifest Cardiovascular Disease: A Novel Approach in Risk Stratification and Treatment Selection
Journal: Current Diabetes Reviews
Volume: 16 Issue: 8 Year: 2020 Page: 869-873
Author(s): Emile Andari,Samir Arnaout,Sami T. Azar,Elie Chammas,Selim Jambart,Mounzer Saleh,Rita Nemr,Antoine Sarkis
Sodium Glucose Cotransporter-2 Inhibitor Treatment and the Risk of Diabetic Ketoacidosis in Denmark: A Retrospective Cohort Study of Five Years of Use
Journal: Current Drug Safety
Volume: 16 Issue: 1 Year: 2021 Page: 73-81
Author(s): Henrik V.B. Laursen,Johan B. Røikjer,Jakob Dal,Morten Hasselstrøm Jensen
Screening GLP-1 Receptor Ligands from Natural Products in Herbs through High-Content Technique
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 22 Issue: 7 Year: 2019 Page: 445-454
Author(s): Kunhao Qin,Shengting Zhang,Jie Wang,Dongbo Liu,Yingying Xiang,Xiuling Ji,Yunlin Wei
Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?
Journal: Current Vascular Pharmacology
Volume: 14 Issue: 6 Year: 2016 Page: 494-497
Author(s): Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis
The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 254-268
Author(s): Marianna Papademetriou,Vasilios G. Athyros,Eleni Geladari,Michael Doumas,Costas Tsioufis,Vasilios Papademetriou
Diabetes Therapy: Novel Patents Targeting the Glucose-Induced Insulin Secretion
Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 4 Issue: 1 Year: 2010 Page: 1-9
Author(s): Sergio Polakof